BFC Planning’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.9K Sell
65
-1
-2% -$57 ﹤0.01% 2896
2026
Q2
$5.23K Buy
66
+11
+20% +$828 ﹤0.01% 2662
2026
Q1
$4.13K Hold
55
– – ﹤0.01% 2380
2025
Q4
$4.35K Hold
55
– – ﹤0.01% 2402
2025
Q3
$3.6K Buy
55
+31
+129% +$1.51K ﹤0.01% 2305
2025
Q2
$948 Hold
24
– – ﹤0.01% 2462
2025
Q1
$724 Sell
24
-81
-77% -$2.65K ﹤0.01% 2484
2024
Q4
$3.67K Hold
105
– – ﹤0.01% 2101
2024
Q3
$4.21K Buy
+105
New +$4.88K ﹤0.01% 2059

Other funds holding IONS

BFC Planning's IONS Position: Q3 2026 in Review

BFC Planning reduced its Ionis Pharmaceuticals (IONS) stake by 1.5% in Q3 2026, selling an estimated $57 and leaving 65 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

BFC Planning first reported a position in IONS in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.23K in Q2 2026. 351 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • BFC Planning held 65 shares of Ionis Pharmaceuticals worth $2.9K as of Q3 2026.
  • BFC Planning sold 1 Ionis Pharmaceuticals share in Q3 2026, an estimated $57.
  • Ionis Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2896 holding.
  • BFC Planning first reported a position in Ionis Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Ionis Pharmaceuticals position peaked at $5.23K in Q2 2026.
  • 351 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.